drugset / Trial / NCT07308236

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

NCT07308236 ↗

Phase 1 Recruiting 10 enrolled Eisai Inc.
NaSingle-groupOpen-labelBasic science

Summary

The primary purpose of this study is to determine the metabolism and excretion of \[14C\]E2086 in healthy male participants.

Timeline

Start
2025-12-31
Primary completion
2026-02-23
Completion
2026-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject E2086 Unknown — Oral

Indications

No indication recorded.